Advertisement
 
YOU ARE HERE: LAT HomeCollectionsPharmanex
IN THE NEWS

Pharmanex

MORE STORIES ABOUT:
FEATURED ARTICLES
BUSINESS
June 2, 1998 | BARBARA MURPHY
Pharmanex in Simi Valley is disputing the Food and Drug Administration's conclusion that Pharmanex's Cholestin is an unapproved drug rather than a dietary supplement. The company said it will revive its lawsuit in federal district court in Utah to seek a ruling that will ensure continued availability of Cholestin to consumers. The FDA has agreed to an expedited court hearing, scheduled June 15 in Salt Lake City.
ARTICLES BY DATE
CALIFORNIA | LOCAL
June 1, 1999 | BARBARA MURPHY
Pharmanex, a research company that develops nutritional supplements, has moved its corporate and research and development headquarters from Simi Valley to the San Francisco Bay area. Company officials said the move places Pharmanex closer to key research and academic centers, including Stanford University and UC San Francisco. "We believe this move provides Pharmanex with greater access to the vast biotechnology resources available in the Bay Area," said company President William McGlashan Jr.
Advertisement
CALIFORNIA | LOCAL
May 4, 1999 | BARBARA MURPHY
Simi Valley-based Pharmanex Inc., which markets natural health supplements, has filed a lawsuit against HPF LLC of Trevose, Pa., in a Utah federal district court alleging trademark violations and unfair trade practices. Pharmanex officials said the suit stems from the similar packaging of Cholestene, a red yeast rice product manufactured by HPF, and the Pharmanex product Cholestin. Pharmanex alleges that the similarities make it confusing for consumers to distinguish between the two products.
CALIFORNIA | LOCAL
May 4, 1999 | BARBARA MURPHY
Simi Valley-based Pharmanex Inc., which markets natural health supplements, has filed a lawsuit against HPF LLC of Trevose, Pa., in a Utah federal district court alleging trademark violations and unfair trade practices. Pharmanex officials said the suit stems from the similar packaging of Cholestene, a red yeast rice product manufactured by HPF, and the Pharmanex product Cholestin. Pharmanex alleges that the similarities make it confusing for consumers to distinguish between the two products.
CALIFORNIA | LOCAL
June 1, 1999 | BARBARA MURPHY
Pharmanex, a research company that develops nutritional supplements, has moved its corporate and research and development headquarters from Simi Valley to the San Francisco Bay area. Company officials said the move places Pharmanex closer to key research and academic centers, including Stanford University and UC San Francisco. "We believe this move provides Pharmanex with greater access to the vast biotechnology resources available in the Bay Area," said company President William McGlashan Jr.
BUSINESS
June 23, 1998 | BARBARA MURPHY
After reviewing information about Cholestin red yeast rice, which is marketed by Pharmanex Inc. of Simi Valley, a federal judge has temporarily overturned an FDA ruling that Cholestin is an unapproved drug. Based on the ruling in the Federal District Court of Utah that Cholestin is a dietary supplement, Pharmanex can continue to import red yeast rice, a fermented yeast found on rice that is ground and used as a staple in Asia. The company sells the yeast under the brand name Cholestin.
CALIFORNIA | LOCAL
November 24, 1998 | LEO SMITH, SPECIAL TO THE TIMES
It's not every day that a manufacturer announces with great optimism the imminent removal of an entire product line from 30,000 stores. But when Simi Valley-based Pharmanex made public recently its plans to withdraw 38 nutritional supplement products from Longs drugstores, Safeway and other leading retailers nationwide, it was seen not as a disaster but as a critical step toward increasing revenue.
CALIFORNIA | LOCAL
March 2, 1999 | BARBARA MURPHY
Pharmanex, an herbal supplement company owned by Nu Skin Enterprises, said it has won a court victory in its battle with U. S. regulators to sell its Cholestin as a cholesterol-lowering dietary supplement. U. S. District Judge Dale Kimball has made final a preliminary order he issued in June allowing Simi Valley-based Pharmanex to continue importing the substances it needs to manufacture and sell Cholestin. The company went to court after the U. S.
BUSINESS
October 13, 1998 | BARBARA MURPHY
Nu Skin Enterprises, a skin-care and nutritional-products company with $890.6 million in 1997 sales, has agreed to buy Generation Health Holdings for as much as $108.1 million in stock, assumed debt and additional payments. Generation Health is the parent of Simi Valley-based Pharmanex, which had about $12 million in sales for the first three quarters of this year and owns plants in China and Chile that make food supplements from herbs and mushrooms.
BUSINESS
October 13, 1998 | BARBARA MURPHY
Nu Skin Enterprises, a skin-care and nutritional-products company with $890.6 million in 1997 sales, has agreed to buy Generation Health Holdings for as much as $108.1 million in stock, assumed debt and additional payments. Generation Health is the parent of Simi Valley-based Pharmanex, which had about $12 million in sales for the first three quarters of this year and owns plants in China and Chile that make food supplements from herbs and mushrooms.
CALIFORNIA | LOCAL
March 2, 1999 | BARBARA MURPHY
Pharmanex, an herbal supplement company owned by Nu Skin Enterprises, said it has won a court victory in its battle with U. S. regulators to sell its Cholestin as a cholesterol-lowering dietary supplement. U. S. District Judge Dale Kimball has made final a preliminary order he issued in June allowing Simi Valley-based Pharmanex to continue importing the substances it needs to manufacture and sell Cholestin. The company went to court after the U. S.
CALIFORNIA | LOCAL
November 24, 1998 | LEO SMITH, SPECIAL TO THE TIMES
It's not every day that a manufacturer announces with great optimism the imminent removal of an entire product line from 30,000 stores. But when Simi Valley-based Pharmanex made public recently its plans to withdraw 38 nutritional supplement products from Longs drugstores, Safeway and other leading retailers nationwide, it was seen not as a disaster but as a critical step toward increasing revenue.
BUSINESS
October 13, 1998 | BARBARA MURPHY
Nu Skin Enterprises, a skin-care and nutritional-products company with $890.6 million in 1997 sales, has agreed to buy Generation Health Holdings for as much as $108.1 million in stock, assumed debt and additional payments. Generation Health is the parent of Simi Valley-based Pharmanex, which had about $12 million in sales for the first three quarters of this year and owns plants in China and Chile that make food supplements from herbs and mushrooms.
BUSINESS
October 13, 1998 | BARBARA MURPHY
Nu Skin Enterprises, a skin-care and nutritional-products company with $890.6 million in 1997 sales, has agreed to buy Generation Health Holdings for as much as $108.1 million in stock, assumed debt and additional payments. Generation Health is the parent of Simi Valley-based Pharmanex, which had about $12 million in sales for the first three quarters of this year and owns plants in China and Chile that make food supplements from herbs and mushrooms.
BUSINESS
June 23, 1998 | BARBARA MURPHY
After reviewing information about Cholestin red yeast rice, which is marketed by Pharmanex Inc. of Simi Valley, a federal judge has temporarily overturned an FDA ruling that Cholestin is an unapproved drug. Based on the ruling in the Federal District Court of Utah that Cholestin is a dietary supplement, Pharmanex can continue to import red yeast rice, a fermented yeast found on rice that is ground and used as a staple in Asia. The company sells the yeast under the brand name Cholestin.
BUSINESS
June 2, 1998 | BARBARA MURPHY
Pharmanex in Simi Valley is disputing the Food and Drug Administration's conclusion that Pharmanex's Cholestin is an unapproved drug rather than a dietary supplement. The company said it will revive its lawsuit in federal district court in Utah to seek a ruling that will ensure continued availability of Cholestin to consumers. The FDA has agreed to an expedited court hearing, scheduled June 15 in Salt Lake City.
CALIFORNIA | LOCAL
May 18, 1999 | BARBARA MURPHY
A Utah federal district judge has issued a preliminary injunction against HPF LLC of Trevose, Pa., in response to a lawsuit filed by Pharmanex Inc. of Simi Valley, a developer of nutritional supplements. Pharmanex claims that confusing similarities exist between the packaging of Cholestene, a red yeast rice product manufactured by HPF, and the Pharmanex product Cholestin, which is designed to promote healthy cholesterol levels. U.S. District Judge Dale A.
CALIFORNIA | LOCAL
November 17, 1998 | BARBARA MURPHY
Pharmanex in Simi Valley has announced plans to fund the UCLA Center for Human Nutrition, Pharmanex Phytochemical Laboratory, the first center of its kind for scientific research in the dietary supplement industry. The laboratory is the culmination of months of planning by Pharmanex and UCLA, establishing a research center to speed the development of standardized dietary supplements.
Los Angeles Times Articles
|